L. Samaranch

发表

Validation of antibodies for neuroanatomical localization of the P2Y11 receptor in macaque brain

B. Kornum, K. Bankiewicz, P. Hadaczek, 2016, Journal of Chemical Neuroanatomy.

Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates.

K. Foust, B. Kaspar, K. Bankiewicz, 2012, Human gene therapy.

Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.

L. Shihabuddin, Seng H. Cheng, M. Fiandaca, 2014, Human gene therapy.

Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants

E. Tolosa, F. Valldeoriola, P. Pástor, 2012, Journal of Molecular Neuroscience.

LRRK2 haplotype‐sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation

E. Tolosa, J. Obeso, M. Rodriguez-Oroz, 2012, Movement disorders : official journal of the Movement Disorder Society.

Lack of interaction of SNCA and MAPT genotypes in Parkinson's disease

E. Tolosa, F. Valldeoriola, P. Pástor, 2011, European journal of neurology.

Analysis of the GIGYF2 gene in familial and sporadic Parkinson disease in the Spanish population

J. Obeso, M. Luquin, M. Rodriguez-Oroz, 2010, European journal of neurology.

Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response

P. Pivirotto, K. Bankiewicz, J. Bringas, 2015, Gene Therapy.

SPG11 compound mutations in spastic paraparesis with thin corpus callosum

J. Masdeu, M. Riverol, P. Pástor, 2008, Neurology.

Widespread optogenetic expression in macaque cortex obtained with MR-guided, convection enhanced delivery (CED) of AAV vector to the thalamus

Philip N. Sabes, A. Yazdan-Shahmorad, Nan Tian, 2018, Journal of Neuroscience Methods.

AAV9-mediated expression of a non-self protein in nonhuman primate central nervous system triggers widespread neuroinflammation driven by antigen-presenting cell transduction.

P. Pivirotto, S. DeArmond, K. Bankiewicz, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates

P. Allen, K. Bankiewicz, J. Bringas, 2018, Molecular therapy. Methods & clinical development.

MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain

H. Petry, K. Bankiewicz, J. Bringas, 2017, Gene Therapy.

AAV viral vector delivery to the brain by shape-conforming MR-guided infusions.

K. Bankiewicz, J. Bringas, J. Forsayeth, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Distribution of nanoparticles throughout the cerebral cortex of rodents and non-human primates: Implications for gene and drug therapy

Ting Xu, K. Bankiewicz, J. Bringas, 2014, Front. Neuroanat..

Safety study of adeno-associated virus serotype 2-mediated human acid sphingomyelinase expression in the nonhuman primate brain.

Y. Hannun, R. Jenkins, R. Richardson, 2012, Human Gene Therapy.

Safety and tolerability of MRI-guided infusion of AAV2-hAADC into the mid-brain of nonhuman primate

J. F. Wright, K. Bankiewicz, J. Bringas, 2014, Molecular therapy. Methods & clinical development.

AAV9-mediated Expression of a Non-self Protein in Nonhuman Primate Central Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-presenting Cell Transduction.

P. Pivirotto, S. DeArmond, K. Bankiewicz, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

PINK1-linked parkinsonism is associated with Lewy body pathology.

P. Pástor, M. Pastor, I. Ferrer, 2010, Brain : a journal of neurology.

Cortical atrophy and language network reorganization associated with a novel progranulin mutation.

Elena Prieto, Javier Arbizu, Josep M Martí-Climent, 2009, Cerebral cortex.

ADENO-ASSOCIATED VIRUS TYPE 6 IS RETROGRADELY TRANSPORTED IN THE NON-HUMAN PRIMATE BRAIN

Krystof S. Bankiewicz, Phillip Pivirotto, John Bringas, 2013, Gene Therapy.

Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington’s disease

P. Pivirotto, L. Shihabuddin, Seng H. Cheng, 2016, Molecular therapy. Methods & clinical development.

Adeno-associated viral vector serotype 9–based gene therapy for Niemann-Pick disease type A

J. Ávila, Seng H. Cheng, E. Schuchman, 2019, Science Translational Medicine.

Mutational Screening of PARKIN Identified a 3′ UTR Variant (rs62637702) Associated with Parkinson’s Disease

V. Álvarez, E. Coto, P. Pástor, 2013, Journal of Molecular Neuroscience.

Analysis of the Micro‐RNA‐133 and PITX3 genes in Parkinson's disease

Marta Blázquez, Pau Pastor, V. Álvarez, 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Genetic variation in APOE cluster region and Alzheimer's disease risk

O. Combarros, M. Bullido, J. Clarimón, 2011, Neurobiology of Aging.

Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP

A. Singleton, J. Molinuevo, J. Hardy, 2010, Neurobiology of Aging.

Lysosomal storage disorders with neurological manifestations

Maria Clarke, Joshua Vignolles-Jeong, L. Samaranch, 2022, Rare Disease and Orphan Drugs Journal.

Forceps Minor Region Signal Abnormality “Ears of the Lynx”: An Early MRI Finding in Spastic Paraparesis with Thin Corpus Callosum and Mutations in the Spatacsin Gene (SPG11) on Chromosome 15

J. Masdeu, M. Riverol, P. Pástor, 2009, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

A Search for SNCA 3′ UTR Variants Identified SNP rs356165 as a Determinant of Disease Risk and Onset Age in Parkinson’s Disease

V. Álvarez, E. Coto, P. Pástor, 2011, Journal of Molecular Neuroscience.

Axonal transport of AAV9 in nonhuman primate brain

A. Manning-Boğ, H. Zhang, K. Meyer, 2016, Gene Therapy.

Axonal transport of adeno-associated viral vectors is serotype-dependent

Gabriele Mittermeyer, Krystof S. Bankiewicz, Shangzhen Zhou, 2012, Gene Therapy.

Infuse-as-you-go convective delivery to enhance coverage of elongated brain targets: technical note.

R. Lonser, M. Fiandaca, K. Bankiewicz, 2020, Journal of neurosurgery.

Development of a novel frameless skull-mounted ball-joint guide array for use in image-guided neurosurgery.

M. Fiandaca, K. Bankiewicz, J. Bringas, 2020, Journal of neurosurgery.

Depletion of AADC activity in caudate nucleus and putamen of Parkinson’s disease patients; implications for ongoing AAV2-AADC gene therapy trial

D. Dickson, S. Goldman, K. Bankiewicz, 2017, PloS one.

Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates.

K. Bankiewicz, J. Bringas, A. Kells, 2013, Human gene therapy.

Guided delivery of adeno-associated viral vectors into the primate brain.

K. Bankiewicz, A. Kells, E. Salegio, 2012, Advanced drug delivery reviews.

Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population

J. Obeso, M. Rodriguez-Oroz, Carlos Cruchaga, 2018, Neurobiology of Aging.

H1-MAPT and the Risk for Familial Essential Tremor

J. Benito-León, P. Pástor, F. Jiménez-Jiménez, 2012, PloS one.

LINGO1 gene analysis in Parkinson's disease phenotypes

P. Pástor, F. Jiménez-Jiménez, J. Irigoyen, 2011, Movement disorders : official journal of the Movement Disorder Society.

Gene Therapy for Misfolding Protein Diseases of the Central Nervous System

K. Bankiewicz, A. Kells, J. Forsayeth, 2013, Neurotherapeutics.

Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS.

L. Shihabuddin, L. Stanek, K. Bankiewicz, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice

I. Ferrer, T. Gómez-Isla, B. Puig, 2005, Neurobiology of Disease.

MR-Guided Delivery of AAV2-BDNF into the Entorhinal Cortex of Non-Human Primates

M. Tuszynski, I. Ivasyk, A. Nagahara, 2018, Gene Therapy.

MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain

H. Petry, K. Bankiewicz, J. Bringas, 2017, Gene Therapy.

GDNF and AADC Gene Therapy for Parkinson’s Disease

K. Bankiewicz, J. Forsayeth, W. S. Sebastián, 2016 .

Nigrostriatal dopaminergic function in subjects with isolated action tremor.

P. Pástor, F. Coria, M. Gimenez-Garcia, 2012, Parkinsonism & related disorders.

Memory decline evolves independently of disease activity in MS

J. Sepulcre, P. Pástor, P. Villoslada, 2008, Multiple sclerosis.

Homocysteine and cognitive impairment in Parkinson's disease: A biochemical, neuroimaging, and genetic study

J. Obeso, J. Kulisevsky, M. Rodriguez-Oroz, 2009, Movement disorders : official journal of the Movement Disorder Society.

Gene Therapy for Misfolding Protein Diseases of the Central Nervous System

K. Bankiewicz, A. Kells, J. Forsayeth, 2013, Neurotherapeutics.

Replication of MAPT and SNCA, but not PARK16‐18, as susceptibility genes for Parkinson's disease

O. Combarros, V. Álvarez, E. Coto, 2011, Movement disorders : official journal of the Movement Disorder Society.

A Search for SNCA 3′ UTR Variants Identified SNP rs356165 as a Determinant of Disease Risk and Onset Age in Parkinson’s Disease

V. Álvarez, E. Coto, P. Pástor, 2012, Journal of Molecular Neuroscience.

The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.

T. Gómez-Isla, J. Clarimón, A. Lleó, 2011, Journal of Alzheimer's disease : JAD.

J. Emparanza, J. Ruiz‐Martinez, P. Martínez-Lage, 2007, Neurobiology of Aging.

Age at Onset in LRRK2-Associated PD is Modified by SNCA Variants

E. Tolosa, F. Valldeoriola, P. Pástor, 2012, Journal of Molecular Neuroscience.

Cerebellomedullary Cistern Delivery for AAV-Based Gene Therapy: A Technical Note for Nonhuman Primates.

P. Pivirotto, K. Bankiewicz, J. Bringas, 2016, Human gene therapy methods.

GDNF gene therapy for alcohol use disorder in male non-human primates

K. Grant, J. McBride, M. Ford, 2023, Nature Medicine.

Translational Fidelity of Intrathecal Delivery of Self-Complementary AAV9–Survival Motor Neuron 1 for Spinal Muscular Atrophy

L. Shihabuddin, Seng H. Cheng, M. Fiandaca, 2014 .

The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.

T. Gómez-Isla, J. Clarimón, A. Lleó, 2011, Journal of Alzheimer's disease : JAD.

Cerebellomedullary Cistern Injection of Viral Vectors in Nonhuman Primates.

K. Bankiewicz, K. Ohno, W. San Sebastián, 2019, Methods in molecular biology.